Eulerpool Terminal
The edge that pays for itself.
Current Compass Therapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
13.50 USD
+606.57 %
Median
12.24 USD
+540.84 %
Max
31.50 USD
Min
8.08 USD
Last Price
1.91 USD
Buy
20
Hold
1
Sell
0
The average target price for Compass Therapeutics is 13.50 USD. (+606.57 % above the current price)
The median price target of Compass Therapeutics is 12.24 USD.
Stock analysts from many renowned investment banks are closely examining the Compass Therapeutics stock. They conclude their professional Compass Therapeutics stock analyses with a clear recommendation for the Compass Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 20 | 1 | 0 | 13.50 USD |
| 2026-01-01 | 19 | 1 | 0 | 13.18 USD |
| 2025-12-01 | 16 | 1 | 0 | 12.55 USD |
| 2025-12-01 | 16 | 1 | 0 | 12.55 USD |
| 2025-11-01 | 16 | 1 | 0 | 12.98 USD |
| 2025-11-01 | 16 | 1 | 0 | 13.17 USD |
Compass Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Compass Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2027e | 25.00 M USD | -82.00 M USD | -0.44 USD |
| 2028e | 204.00 M USD | -3.00 M USD | -0.02 USD |
| 2029e | 363.00 M USD | 101.00 M USD | 0.55 USD |